Bayer
Manufacturing · Germany · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Kaiser-wilhelm-allee 1, Leverkusen, Nord...Phone Number
+49 214301Website
www.bayer.comRevenue
$52.6 BillionStock Symbol
BAYNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
4
4
3
2
1
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture, headquartered in Leverkusen, Germany. The company operates through three divisions: Pharmaceuticals, which focuses on prescription products for cardiology, women's health, oncology, hematology, and ophthalmology; Consumer Health, a supplier of self-care products across dermatology, nutrition, and pain management; and Crop Science, which provides seeds, biotechnology traits, and crop protection products. Bayer serves patients, consumers, and farmers globally, delivering value through a combination of innovative medicines, self-care brands, and digital farming tools designed to improve human health and support sustainable food security.Explore more
Bayer Org Chart
MG
Chief Financial Officer (Brazil)
SB
Directeur Financier Adjoint
JT
Corporate Controller
AO
Analista Contable Y Controller
DB
Product Supply Controller
PA
Site Controller
JM
Manager, Finance & Controller
ZM
Controller
CL
Payroll Accountant and Cost Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bayer your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Bayer, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Bayer has recently received funding, and reach out quickly before it becomes old news!
Check out if Bayer is spiking on competitors!
Earning: See what the market has to say on Bayer recently announced quarterly report
Funding: Get notified immidiatlly once Bayer has new funding data
Product Launch: Get notified when Bayer launches new products
Click to see if Bayer had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Bayer
Recommended Actions
Find VP level buyers at Bayer
Find more new buyers
Explore company insights
Get a deeper look into Bayer's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Bayer is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bayer is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bayer.
Bayer financials insights
Gather financial insights about Bayer, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Private Equity
$3.4B
Bayer Tech Stack
A closer look at the technologies used by Bayer
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Open Position
Bayer News & Media
Bayer Crop Science Targets €3B Cash Flow by 2029 With Seeds-Led Growth
Bayer Aktiengesellschaft (ETR:BAYN) outlined progress on its Crop Science division’s five-year framework at a 2026 innovation event in Iowa, reaffirming targets for above-market sales growth, a mid-20s clean EBITDA margin and more than €3 billion in free operating cash flow by 2029. Rodrigo Santos,AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress
Durham, N.C., Aug. 29, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the presentation of baseline participant characteristics from GenePHIT, one of the largest randomized gene therapy trials conducted in heart failure to date. This presentation highlights the trial’s successful enrollment and further validates that multinational gene therapy trials of this size can be conducted. The PhaseBayer Aktiengesellschaft (BAYRY) Q2 2026 Earnings Call Transcript
Bayer Aktiengesellschaft (BAYRY) Q2 2026 Earnings Call August 4, 2026 3:00 AM EDTCompany ParticipantsMichael Preuss - Head of Communications, Government...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Bayer
Sign Up For FreeTo access detailed company insights
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture, headquartered in Leverkusen, Germany. The company operates through three divisions: Pharmaceuticals, which focuses on prescription products for cardiology, women's health, oncology, hematology, and ophthalmology; Consumer Health, a supplie... Read More
